Oragenics Receives Clinical Hold Letter from FDA

Created on 2022-12-21T23:16:42-06:00

Return to the Index

This card pertains to a resource available on the internet.

This card can also be read via Gemini.

Robert T. Zahradnik, Oragenic Inc, August 2007

Treatment to prevent cavities by replacing mouth bacteria with a harmless variant was killed by the FDA circa 2007.